Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports on an anti-CD19 CAR-T cell therapy being tested in patients with B cell malignancies, including chronic lymphocytic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Lymphocytic Leukemia
• Lymphoma

Drugs mentioned

• Anti-CD19 CAR-T cell therapy (CD19-targeted chimeric antigen receptor T cells)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia | Phase 1 | Status: UNKNOWN